Coral Gables — the City Beautiful — Miami’s multinational-headquarters district along Ponce de Leon and Alhambra — keeps a cosmetics FDA regulatory lawyer busier than almost anywhere in America. Coral Gables hosts more multinational regional headquarters than anywhere else in Florida — the Latin American divisions of global food, beauty, pharmaceutical and device companies run hemispheric operations from its office towers. Product launches, labeling decisions and import programs for entire regions are managed from the Gables. Headquarters-level decisions about FDA-regulated products get made here daily — and headquarters-level mistakes in labeling, claims or registrations are the expensive kind.
Quick answer
MoCRA rebuilt cosmetics regulation: facility registration, product listing, safety substantiation and adverse-event obligations now apply to an industry that spent decades nearly unregulated. Add the old traps — drug claims, color additives, labeling — and cosmetics brands and importers need real regulatory infrastructure for the first time.
Why this matters now
Cosmetics import volume through Miami is enormous and FDA’s screening of it is no longer light-touch: unregistered facilities, unlisted products, drug claims and color-additive violations all surface as detentions. MoCRA converted informal industry habits into federal violations — brands running on pre-2023 practices are accumulating exposure.
The rules in plain terms
The Modernization of Cosmetics Regulation Act (MoCRA) is the biggest change to U.S. cosmetics law since 1938. Most cosmetic facilities must register with FDA and renew biennially, products must be listed, brands must maintain safety substantiation, serious adverse events must be reported, and foreign facilities need a U.S. agent. FDA gained records access and mandatory recall authority over cosmetics.
The classification line remains the industry’s oldest trap: a cosmetic “beautifies and cleanses”; the moment claims promise to treat acne, regrow hair, boost collagen production or alter skin structure, the product is a drug — unapproved, and enforceable as such. Miami’s beauty import trade, one of the largest in the country, meets this line at the border where FDA screens labels shipment by shipment.
Underneath sit the classic rules: color additives must be approved for their use (a strict-liability favorite), labeling must follow FDA and FPLA requirements including INCI ingredient declarations, and talc-containing products now face mandated asbestos testing standards.
How the process works
- MoCRA compliance build-out: facility registration, product listing, U.S. agent arrangements, renewal calendars
- Safety substantiation files — the evidence MoCRA requires brands to hold for every product
- Claims and labeling review: the cosmetic/drug line, ingredient declarations, color-additive verification
- Import compliance for finished goods and components — entry data, supplier documentation, detention response
- Adverse-event procedures and enforcement response, including MoCRA’s new records and recall powers
Serving Coral Gables from Brickell
The work around Coral Gables — multinational regional headquarters, consumer product and beauty brands, trade offices and consulates, medical and pharmaceutical companies, professional services — is FDA-regulated at nearly every turn, and matters here move on the City Beautiful — Miami’s multinational-headquarters district along Ponce de Leon and Alhambra. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
Best practices — and common mistakes
- Assuming cosmetics still need nothing from FDA — MoCRA ended that era
- Marketing copy that makes drug claims a formulation cannot legally support
- Using color additives outside their approved uses — strict liability, no intent required
- Importing for a foreign brand with no U.S. agent and no responsible person designated
- Holding zero safety substantiation because “nobody ever asked” — MoCRA lets FDA ask
Frequently asked questions
What did MoCRA change for cosmetics companies?
Nearly everything structural: mandatory facility registration and biennial renewal, product listing, safety substantiation requirements, serious adverse-event reporting with records retention, U.S. agents for foreign facilities, and FDA mandatory recall authority. Cosmetics went from barely regulated to a registered, inspectable industry.
When does a cosmetic become a drug in FDA’s eyes?
When its intended use — shown by claims on labels, websites and ads — goes beyond cleansing and beautifying into treating conditions or affecting the body’s structure or function. “Reduces the appearance of wrinkles” is cosmetic; “rebuilds collagen” is a drug claim. The wording is the whole game.
Do foreign cosmetics brands selling into the U.S. need registration?
Their manufacturing facilities generally must register (with a U.S. agent), their products must be listed, and a responsible person must handle listings and adverse events. Importers should verify all of it — unregistered-facility shipments are detention candidates.
Why would a cosmetics shipment be detained at the border?
The recurring bases: drug claims on labels, unapproved color additives, missing facility registration, adulteration or microbial concerns, and import-alert matches. Miami sees heavy cosmetics screening; label review before shipping prevents most of it.
What safety substantiation does MoCRA require?
Adequate evidence supporting the safety of each cosmetic product — testing, studies or other reliable data held by the responsible person. There is no filing; the obligation is to possess it and produce it when FDA asks. Brands should build these files product by product, starting with the biggest sellers.